20. 7-22.9) . Socioeconomic status as measured by gross domestic product was inversely associated with symptoms and in total, socioeconomic factors, gender, body mass index, smoking habits and alcohol consumption explained 83.4% of the variance of UGI symptoms.
Conclusions:
There are marked differences in the country specific prevalence of UGI complaints. Socioeconomic factors are closely associated with the prevalence of UGI symptoms. They present with a broad spectrum of intensity and/or frequency While chronic or relapsing UGI symptoms including symptoms of gastrooesophageal reflux (GOR) are most frequently due to so called functional gastrointestinal disorders or gastroesophageal reflux disease (GORD), they significantly impair health-related quality of life and cause a significant burden to society due to reduced work productivity and increased health-care resource utilization (1) (2) (3) (4) (5) . Studies from specific countries and post-hoc analyses reported that the prevalence of dyspepsia, (upper) abdominal pain and the severity of reflux symptoms decreases with advancing age (6) (7) (8) (9) . However, despite their decreasing overall prevalence, more serious GORD-complications like complicated ulcers (i.e. life-threatening bleeding) and adenocarcinoma (10) appear to occur predominantly in elderly patients (11) .
The prevalence of GORD is currently estimated to be in the range from 10-20% (12) , but a recent systematic review suggested significant geographic variations (13) . Other studies suggest an increase of GORD prevalence in recent years (14;15 
METHODS

Subjects
Data were assessed by an online survey with a total of 23.110 interviews taken in a panel of overall 662.700 subjects which represent age-and gender stratified cohorts that are representative for the respective 13 countries. Subjects were members of a fixed panel, and a subset of panellists (n=33135, 5%) was invited to participate in this survey by mail, randomly selected from a telephone directory from the overall panel. To take part in this study, an internet access was required; however, subjects were free to enter this study at any computer with internet access. Predefined numbers of subjects for the various age-strata were included and upon achievement of the predefined numbers, strata were closed.
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Upper gastrointestinal symptom questionnaire
The questions were designed by a group of experts in the field. Internal consistency was reviewed by a steering committee consisting of natives from all countries involved in this trial. After testing for test-retest reliability, the questions were utilized. Two days after study begin, a plausibility check was done to test for responsiveness and construct validity. 
Assessment of the predominant upper gastrointestinal symptom
Prevalence of upper GI symptoms across countries
While upper gastrointestinal and dyspeptic symptoms were highly prevalent in all thirteen countries (overall 37.8%, 95%CI 37.2-38.4 and 11.8%, 95%CI 11.4-12.2), there were marked differences in the prevalence of symptoms, e.g. dyspeptic symptoms ranging from 23.6% in the Netherlands up to 45.3% in Hungary (table 1) . The predominant symptoms in all countries were heartburn and symptoms of gastrointestinal reflux (table 1). In subjects with heartburn, symptoms occurred on average 16.5±41.2 times during the previous 12 months (figure 1).
The influence of age and gender on upper GI symptoms
Overall, females reported a greater prevalence of UGI symptoms than men (table   1) . Interestingly, this was not true in all countries with men in Belgium and Poland, having a higher prevalence of UGI symptoms than females. Women also generally experienced a greater frequency of UGI symptoms compared to men (figure 2). Twenty-seven percent of women (95%CI 26.2-27.8) and 22% men (95%CI 21.2-22.8) reported 13 or more episodes of UGI symptoms. With increasing age, the number of UGI symptom episodes per year increased significantly. Considering the most prevalent UGI symptom "heartburn", the mean frequency of symptomatic episodes was significantly greater in women than in men (18.1±43.5 vs. 14.7±38.5 episodes/ 12 months) and increasing with age. figure 3 ).
The influence of socioeconomic variables on upper GI symptom prevalence
In the bivariate analyses UGI symptoms and dyspepsia were significantly and (table 2) . However, there was a trend for alcohol consumption being associated with dyspepsia, but it failed to reach statistical significance. Similar associations were found for dyspepsia (data not shown).
The per capita GDP was negatively correlated with UGI symptoms and dyspepsia. After stratification for individual income, subjects with a monthly income of less than 1500€/month reported higher rates of UGI symptoms or 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
DISCUSSION
In our study, utilising a large age and gender stratified sample from thirteen countries, the overall prevalence of upper gastrointestinal symptoms was 38% with a marked inter-country variation. However, our data clearly support the notion that there are marked geographic differences in the prevalence of UGI symptoms. Even more importantly besides well recognised risk factors such as BMI and alcohol or nicotine consumption, dyspepsia and the prevalence of UGI symptoms are inversely associated with the GDP per capita and other indicators of wealth such as education, electricity consumption per capita and other markers. This association was still evident after adjusting for potential confounding factors.
In all countries, acidic reflux and heartburn were the most prevalent symptoms.
All symptoms were more prevalent in females. While the proportion of subjects with symptoms decreased with age, symptom episodes were more frequent in the elderly. In our study, the associations between symptoms and smoking or alcohol consumption did not yield significance. On the other hand, an association with GORD symptoms and smoking has been reported previously (22;29) , while the results of an association of GORD symptoms with alcohol consumption are still controversial. The Georgia Medicaid study identified a significant association between a GORD diagnosis and alcohol consumption with an OR 1.8 (95% CI 1.4-2.4). Another study, also, found an association between GORD and alcohol consumption, but only if it was judged excessive (30) . In contrast, alcohol consumption did not significantly affect the risk of a first time diagnosis of GORD in data from the UK GP database study (22) . An excess body mass/ higher body mass index has been reported to be associated with the prevalence of GORD However, this association was observed in the univariate analysis, but did not significantly affect the upper GI symptom prevalence in the multivariate analysis.
The reason for this finding might be the correlation of educational level and monthly income, which also ultimately affect nutritional factors, which were not 12 assessed in this study. We furthermore analyzed the association of individual monthly income with the prevalence of symptoms and demonstrated that a monthly income of less than €1499 was associated with higher rates of upper GI symptoms, while an income exceeding €1500/month was negatively associated with these symptoms. There was also a significant negative association between gross domestic productivity and the reported prevalence of upper GI symptoms and dyspepsia.
To determine whether a higher social status/ income may also result in an increased intake of antacids, we assessed the individual medication taken for upper GI symptoms in various countries. However, we did not find a significant association of PPI use with a decreased rate of upper GI symptoms or dyspepsia, while the use of H2RAs and antacids were associated with higher rates of upper GI symptoms and dyspepsia. Due to the nature of the study, individual co-medication as well as current or past medical history were not assessed. However, it is unlikely that these potential confounders significantly influenced our results.
While our results are based on very large stratified cohorts, there are some limitations of this study that need consideration. The nature of online surveys requires internet access. However, since the subjects were randomly selected from a telephone directory and received their invitation per mail, a personal internet access which may cause bias, was not necessarily required but the questionnaire could have been assessed and answered from any computer with internet access. In our study, predefined numbers of subjects for the various agestrata were included and upon achievement of these predefined numbers, the strata were closed. Therefore data on response rates are not available.
Incentives are often used to maximize study participation in epidemiological studies which in turn raises the question of selection bias. Because bias is (32) . The questionnaire only included four predominant upper gastrointestinal symptoms (heartburn, stomach acid complaints, reflux/ acid taste in the mouth and dyspepsia). Whilst focusing on these core symptoms appears justified by the results of a recent factor analytic study that revealed that these as main factors for the assessment of upper GI symptoms (33) , it is possible that the lack of assessment of other symptoms has limited our understanding of all UGI symptomatology. In our study, for example, we did not assess extra-oesophageal symptoms. On the other hand it can be argued that members of a panel for questionnaire studies are likely to talk about their health and we may thus have overestimated the prevalence of UGI symptoms. We found various associations between sociodemographic and ecologic data and GI symptoms. While it is very unlikely that e.g. the number of mobile phones per 1000 directly affects GI symptoms or underlying disease, there are many factors that might be correlated with mobile utilization that ultimately affect the symptom manifestation. However, the key finding of our study is the fact that beyond reasonable doubt, environmental factors are associated with symptoms. Thus, the ecologic "indicators" tested are indeed linked with the prevalence of symptoms. However, despite these limitations, our findings are in accordance with population-based studies from various Western nations (3;7;18;24;34-36).
In summary, there are marked differences in the country specific prevalence of upper GI complaints. These differences are associated with socioeconomic indicators such as the GDP per capita. Whether these socioeconomic factors and the prevalence of UGI symptoms are linked via specific environmental factors (e.g. nutritional) needs to be elucidated further.
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